| Medical and Health Sciences | Lifetime | 13 | SG 1 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 158 | SG 2 | 99.97 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 1 | SG 1 | 100.00 |
| Ophthalmology | Lifetime | 2 | SG 1 | 99.99 |
| Epidemiology | Lifetime | 84 | SG 1 | 99.87 |
| Nephrology | Lifetime | 221 | SG 1 | 98.26 |
| Cardiology and Cardiovascular Medicine | Lifetime | 877 | SG 4 | 98.00 |
| Obstetrics and Gynecology | Lifetime | 831 | SG 4 | 87.25 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 1 | SG 1 | 99.94 |
| Ophthalmology | 2021-2025 | 5 | SG 1 | 99.84 |
| Health Informatics | 2021-2025 | 75 | SG 3 | 94.73 |
| Epidemiology | 2021-2025 | 590 | SG 4 | 94.54 |
| Glaucoma and retinal disorders | Lifetime | 1 | SG 1 | 99.99 |
| Retinal Diseases and Treatments | Lifetime | 1 | SG 1 | 99.99 |
| Retinal Imaging and Analysis | Lifetime | 1 | SG 1 | 99.99 |
| Retinal and Optic Conditions | Lifetime | 1 | SG 1 | 99.99 |
| Intraocular Surgery and Lenses | Lifetime | 3 | SG 1 | 99.88 |
| Ophthalmology and Visual Impairment Studies | Lifetime | 3 | SG 2 | 99.92 |
| Corneal surgery and disorders | Lifetime | 17 | SG 4 | 99.76 |
| Retinopathy of Prematurity Studies | Lifetime | 4 | SG 2 | 99.50 |
| Cardiovascular Health and Disease Prevention | Lifetime | 73 | SG 1 | 99.49 |
| Chronic Kidney Disease and Diabetes | Lifetime | 50 | SG 1 | 99.57 |
| Traumatic Ocular and Foreign Body Injuries | Lifetime | 22 | SG 1 | 99.24 |
| Blood Pressure and Hypertension Studies | Lifetime | 112 | SG 1 | 99.56 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 47 | SG 1 | 99.08 |
| Digital Imaging for Blood Diseases | Lifetime | 17 | SG 1 | 98.35 |
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 67 | SG 2 | 99.16 |
| Artificial Intelligence in Healthcare | Lifetime | 38 | SG 2 | 98.29 |
| Renal and Vascular Pathologies | Lifetime | 125 | SG 1 | 98.99 |
| Ophthalmology and Visual Health Research | Lifetime | 19 | SG 1 | 98.45 |
| Advanced Glycation End Products research | Lifetime | 127 | SG 1 | 97.93 |
| Acute Ischemic Stroke Management | Lifetime | 446 | SG 5 | 98.67 |
| Connexins and lens biology | Lifetime | 150 | SG 1 | 97.33 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 138 | SG 6 | 96.19 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 848 | SG 5 | 97.95 |
| Dialysis and Renal Disease Management | Lifetime | 459 | SG 3 | 97.94 |
| Ocular Surface and Contact Lens | Lifetime | 471 | SG 8 | 97.32 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 757 | SG 3 | 97.57 |
| Ocular Infections and Treatments | Lifetime | 242 | SG 7 | 97.23 |
| Retinal and Macular Surgery | Lifetime | 287 | SG 3 | 97.41 |
| Cancer and Skin Lesions | Lifetime | 835 | SG 3 | 94.41 |
| Machine Learning in Healthcare | Lifetime | 308 | SG 5 | 92.76 |
| Optical Coherence Tomography Applications | Lifetime | 937 | SG 16 | 92.68 |
| Telemedicine and Telehealth Implementation | Lifetime | 778 | SG 3 | 88.19 |
| Retinal Imaging and Analysis | 2021-2025 | 1 | SG 1 | 99.91 |
| Retinal and Optic Conditions | 2021-2025 | 1 | SG 1 | 99.91 |
| Retinal Diseases and Treatments | 2021-2025 | 2 | SG 1 | 99.89 |
| Glaucoma and retinal disorders | 2021-2025 | 15 | SG 2 | 99.55 |
| Artificial Intelligence in Healthcare and Education | 2021-2025 | 98 | SG 5 | 97.01 |
| Telemedicine and Telehealth Implementation | 2021-2025 | 161 | SG 1 | 92.64 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 253 | SG 5 | 93.06 |
| Machine Learning in Healthcare | 2021-2025 | 214 | SG 8 | 90.76 |
| Artificial Intelligence in Healthcare | 2021-2025 | 274 | SG 3 | 90.43 |
| Retinopathy of Prematurity Studies | 2021-2025 | 95 | SG 1 | 86.95 |
| Ophthalmology and Visual Health Research | 2021-2025 | 47 | SG 3 | 85.62 |
| Renal and Vascular Pathologies | 2021-2025 | 363 | SG 6 | 86.20 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 720 | SG 4 | 86.91 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 804 | SG 6 | 85.00 |
| Ethics in Clinical Research | 2021-2025 | 862 | SG 7 | 73.34 |
